Research · 8 min read
When a Telehealth Program Will Not Prescribe
You paid, you filled in the questionnaire, and the answer was no. Three separate things happen next — a clinical decision exists, a charge sits somewhere, and a record was created — and almost nobody explains any of them in advance.
Key takeaways
- A decline is three separate things: a clinical decision, a charge in some state, and a record that now exists — each with a different owner.
- Federal law puts the prescribing decision with a licensed practitioner, so a support queue can address the charge but cannot reconsider the judgment.
- What you bought decides the money question: an evaluation was delivered, while unshipped merchandise engages the federal rule requiring an offer to cancel with a prompt refund.
- Where the federal health privacy rules apply, you can request the record and the entity must act within thirty days, with one bounded extension and a cost-based fee at most.
- A decline is not a diagnosis, is not permanent, is not on any national list, and is not a coverage denial — and it does not cancel a subscription by itself.
Answer first: three questions, not one
A decline feels like a single event and is really three. Somebody made a clinical decision. A payment is sitting in one of several possible states. And a record now exists with your name on it.
Each of those has a different owner and a different route. Trying to resolve them in one message to one inbox is why the experience so often stalls.
Sort them first. Who decided, and on what basis. What did I actually pay for, and what does that make of the charge. And what does the file say, and how do I get it.
Who actually made the decision
Not the company. Federal drug law describes a drug in this category as dispensed only upon the prescription of a practitioner licensed by law to administer it, or by a refill that prescriber authorized. The authority to write one sits with a licensed individual, and so does the decision not to.
That has a direct consequence for how you follow up. A support queue can tell you about a charge and cannot reconsider a clinical judgment, because it was never theirs to make.
So the first thing worth asking for is the name and credential of the clinician who reviewed your case, and the stated reason. Both are ordinary requests and neither is confrontational.
A program that cannot produce a name has told you something structural about how the review happened. That is worth knowing whether or not you pursue anything further.
What you actually bought decides the money question
This is the distinction that settles most billing disputes in this situation, and it is almost never explained on a checkout page.
If what you purchased was a medical evaluation, the evaluation happened. A decline is a result of the service, not a failure to deliver it, and the terms you agreed to are what govern whether any part of it is refundable.
If what you purchased was merchandise — a medication order priced and sold as a product — then nothing shipped, and a different body of rules speaks to that case. The Federal Trade Commission's rule on mail, internet or telephone order merchandise requires a seller who cannot ship within the applicable time to offer the buyer, clearly and conspicuously and without prior demand, an option either to consent to a delay or to cancel the order and receive a prompt refund.
Many programs sell both in one transaction, which is exactly why the checkout language matters. Look for whether the amount was described as a consultation, a membership, a medication order, or a bundle, because that description is what a later conversation will turn on.
Ask for the breakdown in writing rather than arguing about the total. A charge you can name the parts of is a charge you can discuss.
The record exists, and you may be able to get it
A clinical review that produced a decision produced documentation. That file is worth having, and it is worth having now rather than later.
Where the entity holding it falls under the federal health privacy rules, an individual has a right of access to inspect and obtain a copy of protected health information about them in a designated record set. The entity must act within thirty days, either providing access or issuing a written denial that states its basis in plain language.
It may take a single extension of no more than thirty further days, and only if it gives you a written statement of the reasons and a completion date within the original window. It must provide the information in the form and format you requested where that is readily producible, including an electronic copy where the information is kept electronically. Any fee must be reasonable and cost-based.
Whether a given company falls under those rules is a question about that business rather than something visible from its homepage, so the practical move is to make the request and see what comes back. A request costs nothing and the answer is itself informative.
Ask while the account is open. Retrieving anything from a closed account is the hardest version of this task.
What a decline is not
It is not a diagnosis. A decision not to prescribe a particular medication through a particular program is not a statement about your health, and reading it as one is a common and unnecessary source of distress.
It is not permanent. Circumstances, records and clinical judgment all change, and nothing about one review binds a later one.
It is not recorded in any national registry that other clinicians consult. There is no such list, and worrying about being on it is worrying about something that does not exist.
And it is not a coverage denial. A plan refusing to pay is a different event with a different party and its own appeal machinery. Neither process is an appeal of the other, and mixing the vocabulary sends a letter to a party that cannot act on it.
A sequence that gets it settled
Ask for the reason in writing, along with the name and credential of the reviewing clinician. One message, three specific requests.
Ask separately for the charge breakdown by component, and ask which components the program treats as refundable in this situation. Send that to billing rather than to a clinical channel.
Request your records. Ask for the form and format you want, and note the date you asked, because the clock in the access rule runs from receipt of the request.
Then close the loop on anything recurring. A decline does not automatically stop a subscription that was set up at checkout, and finding that out on the next statement is the avoidable version of this problem.
Where you intend to try elsewhere, having the record in hand first is what makes the next intake a continuation rather than a fresh start.
What this does not decide
It does not tell you whether the decision was right. That is a clinical judgment about you, made by someone with your information, and nothing here evaluates it.
It does not tell you what to do medically, and it does not suggest looking for a clinician who will answer differently. Those are matters for care that can see you.
It does not decide whether you are owed anything. That depends on the terms you agreed to, on what was actually sold, and on the law of your state, none of which is analyzed here.
And it is not legal advice. It describes what a statute and two regulations say and who they bind.
Sources
- 21 U.S.C. § 353, "Exemptions and consideration for certain drugs, devices, and biological products" (subsection (b)(1))That a drug in this category shall be dispensed only upon a written prescription of a practitioner licensed by law to administer such drug, upon that practitioner's oral prescription reduced promptly to writing and filed by the pharmacist, or by refilling such a prescription where the refill is authorized by the prescriber. This supports the statement that the decision to prescribe, and therefore the decision not to, belongs to a licensed individual rather than to a company or a support queue.
- 16 CFR Part 435, "Mail, Internet, or Telephone Order Merchandise" (§ 435.2(b))That where a seller is unable to ship merchandise within the applicable time, it is an unfair or deceptive act or practice to fail to offer the buyer, clearly and conspicuously and without prior demand, an option either to consent to a delay in shipping or to cancel the order and receive a prompt refund. Cited here only for the narrow point that an unshipped merchandise order and a delivered service are governed differently; the part's full mechanics are not restated in this article.
- 45 CFR 164.524, "Access of individuals to protected health information"The right of access to inspect and obtain a copy of protected health information in a designated record set; the requirement to act within 30 days of receipt by granting access or issuing a written denial that is in plain language and states its basis; the single permitted extension of no more than 30 further days, conditioned on a written statement of reasons and a completion date provided within the original window; provision in the requested form and format where readily producible, including an electronic copy where the information is maintained electronically; and the limitation of any fee to a reasonable, cost-based one.
Frequently asked questions
Who decided not to prescribe — the company or a clinician?
A clinician, and the distinction is practical rather than pedantic. Federal drug law describes a drug in this category as dispensed only on the prescription of a practitioner licensed by law to administer it, or by a refill that prescriber authorized. The authority to write one belongs to a licensed individual, so the decision not to write one does as well. That is why a support queue cannot reconsider it: the judgment was never theirs. Ask for the name and credential of the reviewing clinician along with the stated reason, in one written message.
Am I owed my money back?
That depends on what was actually sold, and the answer is in your terms rather than in any general rule. If you bought a medical evaluation, the evaluation occurred and a decline is its result rather than a failure to deliver. If you bought merchandise that never shipped, the Federal Trade Commission's rule on mail, internet or telephone order merchandise requires a seller unable to ship within the applicable time to offer the buyer, clearly and conspicuously and without prior demand, the option to consent to a delay or to cancel and receive a prompt refund. Many checkouts bundle both, so ask for the charge broken down by component in writing.
Can I get the notes from the review?
Often yes, and it is worth asking. Where the entity holding the record is subject to the federal health privacy rules, you have a right of access to inspect and obtain a copy of protected health information about you in a designated record set. The entity must act within thirty days, either granting access or issuing a written denial stating its basis in plain language, with at most one thirty-day extension that requires written reasons and a completion date given inside the original window. It must honor your requested format where readily producible, and any fee must be reasonable and cost-based. Ask while the account is still open.
Does a decline go on a permanent record somewhere?
There is no national registry of people a telehealth program declined to prescribe for, and no list that other clinicians consult. What exists is documentation held by the entity that performed the review, which is the same kind of record any clinical encounter generates. A decision not to prescribe a particular medication through a particular program is also not a diagnosis and should not be read as a statement about your health. It is a decision about one medication, made at one time, on the information available then.
Is this the same as an insurance denial?
No, and treating them as the same wastes weeks. A coverage denial is a plan declining to pay for something a clinician has prescribed, and it has its own machinery — reconsideration, formulary exceptions, internal and external appeals. A decline to prescribe is a clinical decision by a licensed individual and there is no plan involved at all. Neither process appeals the other. Sending an appeal letter about a clinical decision to a plan, or a coverage argument to a clinician, produces a referral rather than an answer, which is the usual way this confusion shows up.
Does a decline cancel my subscription?
Not necessarily, and this is the part that produces the second unpleasant surprise. Enrollment at checkout and clinical approval are separate steps, and a recurring charge set up during the first does not automatically stop because of the second. Check your statement rather than assuming, confirm in writing what has been cancelled and what remains active, and keep that confirmation. If a charge you did not expect appears afterward, the sequence to follow is the ordinary cancellation and billing one, which is a commercial question rather than a clinical one.